3-[4-[(3-benzyltriazol-4-yl)methoxy]-2-hydroxyphenyl]-1-phenylpyrazole-4-carbaldehyde
C26H21N5O3 — CID 139593977
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-[4-[(3-benzyltriazol-4-yl)methoxy]-2-hydroxyphenyl]-1-phenylpyrazole-4-carbaldehyde
3-[4-[(3-benzyltriazol-4-yl)methoxy]-2-hydroxyphenyl]-1-phenylpyrazole-4-carbaldehyde (PubChem CID 139593977) has the molecular formula C26H21N5O3 and a molecular weight of 451.49 g/mol. Its IUPAC name is 3-[4-[(3-benzyltriazol-4-yl)methoxy]-2-hydroxyphenyl]-1-phenylpyrazole-4-carbaldehyde.
Molecular Properties
| Compound Name | 3-[4-[(3-benzyltriazol-4-yl)methoxy]-2-hydroxyphenyl]-1-phenylpyrazole-4-carbaldehyde |
|---|---|
| PubChem CID | 139593977 |
| Molecular Formula | C26H21N5O3 |
| Molecular Weight | 451.49 g/mol |
| Exact Mass | 451.16 |
| IUPAC Name | 3-[4-[(3-benzyltriazol-4-yl)methoxy]-2-hydroxyphenyl]-1-phenylpyrazole-4-carbaldehyde |
| SMILES | O=Cc1cn(-c2ccccc2)nc1-c1ccc(OCc2cnnn2Cc2ccccc2)cc1O |
| InChI | InChI=1S/C26H21N5O3/c32-17-20-16-30(21-9-5-2-6-10-21)28-26(20)24-12-11-23(13-25(24)33)34-18-22-14-27-29-31(22)15-19-7-3-1-4-8-19/h1-14,16-17,33H,15,18H2 |
| InChIKey | LXDUHEDRTXCPFX-UHFFFAOYSA-N |
| XLogP | 4.28 |
| TPSA | 95.06 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 451.49 |
| LogP ≤ 5 | 4.28 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 8 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'aldehyde', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 139593977 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.